| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HUMIMM.2006.08.001 |
| P8608 | Fatcat ID | release_zrp5idvcozalrprdt476gxsn5m |
| P932 | PMC publication ID | 2169290 |
| P698 | PubMed publication ID | 17145365 |
| P5875 | ResearchGate publication ID | 6654405 |
| P2093 | author name string | Rene J Duquesnoy | |
| P2860 | cites work | Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 |
| Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfaces | Q27619619 | ||
| Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,) | Q27622663 | ||
| Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen | Q27640276 | ||
| Solution structure and activity of mouse lysozyme M | Q27640600 | ||
| High-resolution three-dimensional structure of horse heart cytochrome c | Q27668194 | ||
| Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex | Q27728062 | ||
| Structure of an antibody-lysozyme complex unexpected effect of conservative mutation | Q27729412 | ||
| Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme | Q27729792 | ||
| Bound water molecules and conformational stabilization help mediate an antigen-antibody association | Q27731557 | ||
| Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme | Q27734142 | ||
| Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex | Q27747455 | ||
| A mutational analysis of binding interactions in an antigen-antibody protein-protein complex | Q27758122 | ||
| Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution | Q27765034 | ||
| Standard conformations for the canonical structures of immunoglobulins | Q28254522 | ||
| Conformations of immunoglobulin hypervariable regions | Q28273335 | ||
| HLA‐B15: A widespread and diverse family of HLA‐B alleles | Q28286688 | ||
| Unraveling hot spots in binding interfaces: progress and challenges | Q29614463 | ||
| Anatomy of hot spots in protein interfaces | Q29616238 | ||
| Somatic generation of antibody diversity | Q29616439 | ||
| On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5. | Q30195996 | ||
| Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures | Q30746440 | ||
| HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients | Q33369144 | ||
| Binding in the growth hormone receptor complex | Q33593803 | ||
| Interactions of protein antigens with antibodies | Q33594252 | ||
| Anatomy of the antibody molecule | Q34060425 | ||
| Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity | Q34179284 | ||
| Cloning and expression of the cDNA for the murine interferon gamma receptor | Q34317120 | ||
| Three-dimensional structure of an antibody-antigen complex | Q34366479 | ||
| Energetic and kinetic contributions of contact residues of antibody D1.3 in the interaction with lysozyme | Q34413120 | ||
| Reductionism and the search for structure-function relationships in antibody molecules | Q35007284 | ||
| Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies | Q69000243 | ||
| Site-directed chemical modification of horse cytochrome c results in changes in antigenicity due to local and long-range conformational perturbations | Q69002528 | ||
| The expressed lysozyme-specific B cell repertoire. I. Heterogeneity in the monoclonal anti-hen egg white lysozyme specificity repertoire, and its difference from the in situ repertoire | Q71000652 | ||
| HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes | Q71585528 | ||
| Comparison of a structural and a functional epitope | Q71601556 | ||
| Antigenic regions defined by monoclonal antibodies correspond to structural domains of avian lysozyme | Q72733543 | ||
| HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival | Q73180837 | ||
| Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins | Q73919852 | ||
| Immunological speculations | Q79123866 | ||
| The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome | Q80389325 | ||
| Is the application of HLAMatchmaker relevant in kidney transplantation? | Q81308319 | ||
| HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. | Q52009690 | ||
| The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. | Q52041496 | ||
| HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. | Q52041499 | ||
| HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. | Q52041500 | ||
| Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices. | Q52893012 | ||
| A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3. | Q52941721 | ||
| Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches | Q61053434 | ||
| Protein antigenicity: A thermodynamic approach | Q67687408 | ||
| Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution | Q67694554 | ||
| Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme | Q67723990 | ||
| Patterns of antibody specificity during the BALB/c immune response to hen eggwhite lysozyme | Q67927284 | ||
| Amino acid residues on HLA molecules critical for alloantibody binding | Q68188123 | ||
| Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding | Q68564328 | ||
| Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17 | Q68963626 | ||
| Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution | Q68969863 | ||
| Extending options for highly sensitized patients to receive a suitable kidney graft | Q36220802 | ||
| High-resolution mapping of the HyHEL-10 epitope of chicken lysozyme by site-directed mutagenesis | Q36273475 | ||
| Energetic analysis of an antigen/antibody interface: alanine scanning mutagenesis and double mutant cycles on the HyHEL-10/lysozyme interaction | Q36281533 | ||
| Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon | Q36353547 | ||
| Epitopes on protein antigens: misconceptions and realities. | Q36576238 | ||
| Antibody-antigen complexes | Q37943232 | ||
| The atomic mobility component of protein antigenicity | Q38154881 | ||
| Structural and functional approaches to the study of protein antigenicity | Q38208203 | ||
| HLA-DR and -DQ epitopes and monoclonal antibody specificity | Q38209752 | ||
| How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme? | Q38270409 | ||
| The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme | Q38313296 | ||
| A proposal for the nomenclature of antigenic sites in peptides and proteins | Q39524030 | ||
| The chemistry and mechanism of antibody binding to protein antigens. | Q39539172 | ||
| Structure of antibody-antigen complexes: implications for immune recognition. | Q39539191 | ||
| The structural basis of antibody complementarity | Q39779292 | ||
| The antigenic structure of proteins: a reappraisal. | Q40076398 | ||
| Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies | Q40360031 | ||
| Antibody-antigen interactions: new structures and new conformational changes | Q40399620 | ||
| Antibody structure and the evolution of immunoglobulin V gene segments | Q40471075 | ||
| Recent origin of the P lysozyme gene in mice | Q40515705 | ||
| The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder | Q40802303 | ||
| Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. | Q41167755 | ||
| Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope | Q41188726 | ||
| Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopes | Q41285221 | ||
| Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites | Q41295516 | ||
| HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902. | Q41396339 | ||
| Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix | Q41434617 | ||
| Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope | Q41466223 | ||
| HLA-DRβ chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes | Q41557902 | ||
| Cn3D: a new generation of three-dimensional molecular structure viewer | Q41576502 | ||
| HLA-B∗0702 antibody epitopes are affected indirectly by distant antigen residues | Q41577346 | ||
| Mutagenesis around residue 176 on HLA-B∗0702 characterizes multiple distinct epitopes for anti-HLA antibodies | Q41602436 | ||
| Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system | Q41649533 | ||
| Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms | Q41665170 | ||
| HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes | Q42665365 | ||
| Monoclonal antibodies to horse cytochrome c expressing four distinct idiotypes distribute among two sites on the native protein. | Q42800818 | ||
| Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes | Q44398319 | ||
| Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c. | Q44839695 | ||
| HLA epitope matching. Contribution of matched residues to epitopes recognized by alloantibodies | Q45162670 | ||
| Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces | Q45255575 | ||
| Association of the anti-hen egg lysozyme antibody HyHEL-5 with avian species variant and mutant lysozymes. | Q46017243 | ||
| Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort | Q46984237 | ||
| Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. | Q47425669 | ||
| Antibody-antigen interactions: contact analysis and binding site topography. | Q47628744 | ||
| The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens | Q47683551 | ||
| Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. | Q47700146 | ||
| Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation | Q47785748 | ||
| Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. | Q48306828 | ||
| Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty. | Q51034692 | ||
| Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. | Q51941761 | ||
| HLA class I donor-specific triplet antibodies detected after renal transplantation. | Q51990427 | ||
| Humoral sensitization against rejected grafts: specific antibodies to graft immunogenic amino acid triplets. | Q51990430 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 847-862 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | A structurally based approach to determine HLA compatibility at the humoral immune level | |
| P478 | volume | 67 |
| Q43918489 | 16th IHIW: a website for antibody-defined HLA epitope Registry |
| Q46642899 | A group-specific sequencing approach to investigate the presence of atypical human leucocyte antigen alleles |
| Q41252650 | A new HLA-A*26 family allele--HLA-A*26:103. |
| Q43764339 | A new approach to HLA typing designed for solid organ transplantation: epityping and its application to the HLA-A locus |
| Q47868324 | A novel HLA-B*14 allele - B*14:53 - genetics and serology |
| Q26766411 | Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen |
| Q37252505 | Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching |
| Q50853819 | Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets. |
| Q37853627 | Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications |
| Q57171889 | Assessment of human leukocyte antigen immunogenicity: current methods, challenges and opportunities |
| Q53217713 | Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? |
| Q50879242 | Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q61801142 | Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation |
| Q37670811 | Computational Approaches to Facilitate Epitope-Based HLA Matching in Solid Organ Transplantation |
| Q55396590 | Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods. |
| Q89481944 | Critical evaluation of a possible role of HLA epitope matching in kidney transplantation |
| Q30403833 | De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients |
| Q87022669 | Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation |
| Q39221154 | Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation |
| Q64263915 | Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff |
| Q51621019 | Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. |
| Q38204851 | Detection of donor-specific antibodies in kidney transplantation |
| Q54162984 | Detection of newly antibody-defined epitopes on HLA class I alleles reacting with antibodies induced during pregnancy. |
| Q34796926 | Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response |
| Q51354461 | EpHLA software: a timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes. |
| Q48153546 | Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities |
| Q90624940 | Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis |
| Q51720109 | Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies. |
| Q44714808 | First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry |
| Q34353750 | Generation of a highly reactive chicken-derived single-chain variable fragment against Fusarium verticillioides by phage display |
| Q50247563 | HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction |
| Q28074462 | HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act |
| Q42178035 | HLA antibody testing: a tool to facilitate not to prevent organ transplantation |
| Q51091761 | HLA epitope based matching for transplantation. |
| Q39044089 | HLA epitope matching in pediatric renal transplantation |
| Q60301023 | HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment |
| Q38364484 | HLA epitopes as viewed by antibodies: what is it all about? |
| Q48704136 | HLA incompatible combined liver-kidney transplantation: dynamics of antibody modulation revealed by a novel approach to HLA antibody characterisation. |
| Q87167385 | HLA-A2 reactive antibodies in a patient who types as HLA-A2: The importance of high resolution typing and epitope-based antibody analysis |
| Q36874597 | HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients |
| Q36858319 | HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. |
| Q90184811 | High-resolution human leukocyte antigen typing and early post-transplant outcomes: more than meets the eye |
| Q48005375 | Highly Immunogenic DQB1 Mismatch Eplets Are Associated With Development of Chronic Active Antibody-Mediated Rejection: A First Report From Japan |
| Q92142336 | Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance |
| Q51639128 | Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets |
| Q42044561 | Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity |
| Q60168146 | Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation |
| Q90450871 | In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance |
| Q52310243 | Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. |
| Q38192307 | Nothing's perfect: the art of defining HLA-specific antibodies |
| Q33606649 | Opportunities for Engaging Patients in Kidney Research |
| Q35237720 | Optimal HLA matching in hematopoietic cell transplantation |
| Q52647757 | PIRCHE-II Is Related to Graft Failure after Kidney Transplantation. |
| Q40380942 | Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy. |
| Q59807111 | Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential |
| Q33608371 | Predicting alloreactivity in transplantation |
| Q50759708 | Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant. |
| Q37300446 | Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes |
| Q40925162 | Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized |
| Q58194089 | Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution Rather Than the Antigen Level? |
| Q35022239 | Strategies to increase the donor pool and access to kidney transplantation: an international perspective |
| Q33377376 | Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? |
| Q37085307 | Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns |
| Q48397261 | The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients |
| Q30397251 | The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies |
| Q42317060 | The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA. |
| Q38252850 | The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity? |
| Q90346271 | The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide |
| Q37943469 | The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity |
| Q89741707 | The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients |
| Q48656814 | The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation |
| Q57811762 | The long and winding road towards epitope matching in clinical transplantation |
| Q90182097 | The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients |
| Q90745717 | Transplanting the Elderly: Mandatory Age- and Minimal Histocompatibility Matching |
| Q35646594 | Usefulness of the Nonself-Self Algorithm of HLA Epitope Immunogenicity in the Specificity Analysis of Monospecific Antibodies Induced during Pregnancy |
| Q37808761 | Virtual crossmatch approach to maximize matching in paired kidney donation |
| Q37300454 | Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? |
Search more.